JPRN-UMIN000015179
Completed
未知
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL) - The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)
agoya University Graduate School of Medicine0 sites30 target enrollmentSeptember 16, 2014
ConditionsAcute lymphoblastic leukemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute lymphoblastic leukemia
- Sponsor
- agoya University Graduate School of Medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disordersISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212
Recruiting
Phase 2
The effect of Intravenous immunoglobulin on COVID-19 infectioIRCT20200418047116N1Gonabad University of Medical Sciences20
Not yet recruiting
Not Applicable
Efficacy of intravenous immunoglobulin replacement therapy for hypogammaglobulinemia in severe infectionssevere infectious diseasesJPRN-UMIN000032802Sapporo Medical University300
Completed
Phase 2
The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocolCOVID-19 disease.COVID-19, virus identifiedU07.1IRCT20200325046859N1Mashhad University of Medical Sciences50
Terminated
Phase 4
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated MyelopathyHIV-associated MyelopathyNCT01561755David M. Simpson12